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Aim: To phenotype and genetically map the disease locus in a family presenting with autosomal domi-
nant microcornea, rod-cone dystrophy, cataract, and posterior staphyloma.
Methods: Six affected and three unaffected members of the pedigree were examined. All individuals
provided a history and underwent a full clinical examination with A-scan and B-scan ultrasonography
and electrophysiological testing where appropriate. PCR based microsatellite marker genotyping using
a positional candidate gene approach was then performed on DNA samples extracted from venous
blood provided by each subject.
Results: The disorder is inherited as an autosomal dominant trait with variable expressivity and has a
complex phenotype. Affected individuals had bilateral microcornea, pulverulent-like lens opacities, a
rod-cone dystrophy and posterior staphyloma (MRCS). Using a positional candidate gene approach,
the authors have evidence suggestive of linkage of this disorder to a region on 11q13 within the nano-
phthalmos 1 (NNO1) genetic interval. The small family size militates against achieving a LOD score of
3, but the haplotype data and the position of the putative MRCS locus within a known nanophthalmos
locus are suggestive of linkage. A candidate gene within this region (ROM1) was screened and no
mutations were found in affected members of the family.
Conclusion: This rare developmental disorder has some phenotypic similarities to nanophthalmos and
possibly maps to a locus within the genetic interval encompassing the NNO1 locus. Screening of can-
didate genes within this region continues.
Eye development is directed by the coordinated temporaland spatial interaction of a number of genes and theirproducts. A mutation in any one of these developmental
genes therefore would be predicted to manifest as a complex
ocular phenotype affecting multiple structures within the eye.
An increasing number of genes have been identified as caus-
ing various forms of anterior segment dysgenesis and abnor-
malities of ocular size. Some—for example PAX6 1, CHX10,2 and
SIX3,3 are associated with small eyes and others, PITX2,4
PITX3,5 FOXC1,6 FOXE3,7 PAX6,8 EYA1,9 MAF,10 and CYP1B1,11 are
associated with anterior segment dysgenesis.
A number of clinical disorders affecting development of the
globe are recognised. Anophthalmia is a term used to describe
complete absence of the globe; this is however a histological
diagnosis and rare as small remnants of ocular tissue are usu-
ally present within the orbit.12 The term clinical anophthalmos
is more appropriate to describe patients who appear to have no
ocular structures on clinical examination. In microphthalmos,
the eye is small13 and there is often associated ocular
coloboma.14 Anophthalmos and microphthalmos probably
form part of the same disease spectrum and both may be seen
within the same family.15 Asymmetrical or strictly unilateral
involvement may be seen. Both may be associated with other
systemic abnormalities.
Nanophthalmos, described by some authors as “simple
microphthalmia,”12 is an uncommon usually bilateral ocular
condition characterised by a small eye with (a) a reduced axial
length, (b) high hyperopia16 (+7.00 D to + 13.00 D), (c) a high
lens/eye volume ratio, (d) a high incidence of angle closure
glaucoma,17 and (e) characteristic yellow macular pigmenta-
tion, chorioretinal folds, and crowded optic discs.18 Ocular
ultrasound commonly reveals a thickened sclera composed of
abnormal collagen fibrils19 which may obstruct the outflow of
blood through the vortex veins resulting in recurrent or
persistent choroidal effusions16 and non-rhegmatogenous
retinal detachments. Rarely, nanophthalmos has been re-
ported in association with a pigmentary retinopathy.20–22
Nanophthalmia is usually sporadic but may be inherited as
an autosomal dominant or recessive trait. It can also be seen in
association with other systemic congenital abnormalities.13
The genetic locus for the recessive form of nanophthalmos has
not been identified but linkage analysis of a single dominant
family has assigned a locus (NNO1)23 from 11p12 to 11q13 (an
interval close to but excluding the PAX6 gene1).
In this paper, we report the findings in a three generation
English family with an autosomal dominant ocular phenotype
comprising microcornea, rod cone dystrophy, cataract, and
posterior staphyloma (MRCS) possibly mapping genetically
within the NNO1 locus on chromosome 11. The implications of
this observation are discussed.
SUBJECTS AND METHODS
Subjects
The clinical genetic database at Birmingham Women’s Hospi-
tal, Birmingham, UK, was used to identify a family, the
affected members of which exhibited a complex developmen-
tal disorder of the eye. Eleven members of the family agreed to
take part in the study (Fig 1). The study had the approval of
the Moorfields Eye Hospital ethics committee. Informed con-
sent for clinical and genetic investigations was obtained from
all participants.
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Clinical examination
An ophthalmic and general medical history was obtained and
each patient underwent a systemic and full ophthalmic exam-
ination. The ophthalmic examination included assessment of
visual acuity and detailed examination of the anterior and
posterior segments and tonometry. Five individuals under-
went electroretinography and two had electro-oculography.
Older subjects had electroretinography performed according
to ISCEV protocol,24 but the children who were unable to tol-
erate gold foil electrodes had electroretinograms performed
with the skin electrodes. Six affected individuals also had
A-scans and B-scan ultrasonography.
Genotyping
Genomic DNA was extracted from EDTA sequestered blood
samples taken using the Nucleon II DNA extraction kit (Scot-
lab Bioscience). PCR based genotyping using microsatellite
markers (dinucleotides, trinucleotides, and tetranucleotides)
were used. The amplified PCR products were resolved by 6%
non-denaturing polyacrylamide gel electrophoresis (Protogel;
National Diagnostics, Atlanta, GA, USA) and were visualised
by staining with ethidium bromide. Subsequent genotyping
and haplotype analysis were performed manually. We used a
positional candidate gene approach to determine whether loci
associated with small eyes or nanophthalmia were responsible
for this unusual syndrome. Candidate loci were located on the
long arm of chromosome 14 (CMIC25and CHX102), chromo-
some 11 (NNO123 and PAX61) and the long arm of
chromosome 15 (NNO226). Pedigree data were collated with
pedigree mapping software (version 2.1.3; Cherwell Scientific
Publishing Ltd, The Magdalen Centre, Oxford Science Park,
Oxford, UK) and two point linkage analysis performed using
the MLINK component of the LINKAGE program, version 5.127
using an autosomal dominant model, equal allele frequencies,
a gene frequency of 10−4, and a mutation rate of 10−6.
Mutation screening
Mutation screening of a possible candidate gene, ROM1,
within this region was performed. Coding exons and flanking
splice junctions were screened for mutations by direct
sequencing. Reactions were performed in a 50 µl volume with
200 ng of genomic DNA; 20 pmol of each primer; 200 µM each
dATP, dCTP, dTTP, dGTP; 10 mM TRIS-HCl (pH 8.3); 1.5 mMol
MgCl2, and 0.5 U Taq DNA polymerase (Bioline Biotaq). After
Figure 1 Family pedigree and
haplotype analysis using
microsatellite markers on 11q13.
Affected individuals are denoted by
solid symbols.
Table 1 Clinical evaluation of the phenotype
II5 II7 III2 III4 IV1 IV2
Sex F M M F F M
Age 52 56 34 39 14 9
VA
Right 2/36 NPL HM 6/36 6/9 6/9
Left 1/18 NPL HM PL 6/18 6/9
Cornea (mm)
Right (horizontal/vert) 9/9 10/10 8/8 8.5/8.25 9/8.7 8/8.25
Left (horizontal/vert) 9/9 10/10 8/8 8.75/8.2 8.7/8.7 8.25/8
Refraction
Right +15.00/+3.0×90 −0.75/−1.00×85 −1.00/−3.00×160
Left +15.00/+3.0×90 −1.00 −1.75/−1.75×25
Lens Aphakic Aphakic Aphakic Aphakic Pulverulent Pulverulent
AL (mm)
Right 25.04 25.6 16.44 22.68 23.04 22.82
Left 25.12 25.6 16.63 18.73 22.92 22.71
ERG Extinguished Extinguished Not done Severely reduced Subnormal Subnormal
EOG (light rise) Not done Not done Not done 110% 150% Not done
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the initial denaturation step at 95°C for 3 minutes, the samples
were processed through 30 cycles of 95°C for 30 seconds,
55–60°C for 30 seconds, and 72°C for 45 seconds. A final
extension step was performed at 72°C for 5 minutes. After
amplification, PCR products were processed using a PCR puri-
fication kit (Quickstep PCR Purification Kit) according to the
manufacturer’s instructions. A volume of 1.5 µl of the purified
PCR product was used in a sequencing reaction. Both the for-
ward and reverse strands of the PCR products were directly
sequenced (ABI 373 sequencer, using the ABI prism BigDye
Terminator cycle sequencing ready reaction kit; PE applied
Biosystems, Foster City, CA, USA). Sequencing reactions were
set up according to the manufacturer’s instructions, using
either the forward or reverse primers.
RESULTS
Six individuals, three males and three females (age range 9–56
years), were found to be affected. The disorder was inherited
as an autosomal dominant trait. Typically patients complained
of night blindness during their teenage years and poor vision
due to cataracts before the age of 30. Cataract surgery was
performed in the second or third decade. One affected member
(III:2) was unavailable to attend for a comprehensive assess-
ment, but review of his clinical records revealed the findings of
microcornea, a pigmentary retinopathy, and previous cataract
surgery. Older individuals had poor vision (ranging from no
perception of light to 20/400) at the time of examination while
the younger individuals retained good visual acuities (20/30)
(Table 1). All individuals had small corneas (Table 1 and Fig 2A
and B) and two older individuals (II5 and II7) had chronic
angle closure glaucoma. Younger individuals had pulverulent-
like cataracts, whereas older individuals were aphakic as a
result of previous cataract surgery. The phakic individuals
were moderately myopic (Table 1).
All affected members had retinal abnormalities consisting
of peripheral retinal pigment epithelium atrophy and retinal
pigmentation. In addition, there was evidence of a posterior
staphyloma in nine of 12 eyes. The younger individuals
showed a clearcut demarcation line, which may be related to
the boundary of the staphyloma. Anterior to this line was evi-
dence of retinal pigmentation (Fig 2C). Older individuals dis-
played no such boundary and pigmentation was seen
throughout the posterior pole (Fig 2D) and into the posterior
staphyloma.
No systemic disease or abnormality was identified as segre-
gating with the retinal disease. Although clinical examination
Figure 2 (A) and (B) Microcornea in individual II5. (C) Left inferonasal peripheral fundal view in individual IV1 showing demarcation line. (D)
The right posterior pole in individual II:7 with arrow depicting the optic disc. (E) Oblique longitudinal ultrasound section demonstrating the
posterior staphyloma in the left eye (individual II:5) SUP = superior, INF = inferior, POST = posterior, A = anterior.
Figure 3 Flash ERGs. Left panel: control; middle panel: patient IV:1;
right panel: patient II:7. LA = light adapted. DA = dark adapted. SF =
standard flash (ISCEV protocol, see text). OPs = oscillatory potentials.
The vertical broken line indicates stimulus onset.
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showed some features consistent with a diagnosis of nanoph-
thalmos, patients did not show consistently reduced axial
length. Ultrasonography of nearly all individuals showed
abnormally shaped eyes with posterior staphylomata (Fig 2E),
but eye sizes within the normal range. The exceptions were
individuals III:2 and III:4. III:4 had a posterior staphyloma in
one eye and a shortened axial length (without posterior
staphyloma) in the other.
The electroretinogram (ERG) was extinguished (Fig 3) in
the two older members of the family (average age 54 years).
Subnormal photopic and scotopic responses were demon-
strated in individuals III:4 and her children IV:1 and IV:2. In
Individual IV:1 the scotopic responses were reduced compared
to the photopic responses (Fig 3).
Molecular analyses
Markers on 14q excluded the congenital microphthalmia
(CMIC) locus and CHX10. Markers on 15q also excluded the
NNO2 locus (Table 2). The maximum score for this small fam-
ily using autosomal dominant inheritance was 2.01 with
marker D11S1765 at recombination fraction of zero. A LOD
score of 1.98 at θ =0 was also achieved for marker D11S4076
(0.84 cM telomeric to D11S1765). D11S4191 and D11S1883
were flanking markers with recombinant events, therefore
defining a likely 5.0 cM genetic interval within the NNO1
locus. The haplotypes are presented in Figure 1. This region
contained several genes one of which, ROM1, is a candidate
gene for retinal dystrophy. No sequence change that co-
segregated with disease was found in the promoter and coding
sequences of this gene.
DISCUSSION
The features of microcornea, rod-cone dystrophy, pulverulent
cataract, and posterior staphyloma segregate together in this
family and represent a rare ocular phenotype (MRCS). The
clinical findings of microcornea and angle closure glaucoma
are similar to those found in nanophthalmia but in our family
most eyes showed apparently normal axial lengths. Indeed the
phakic eyes were myopic (Table 1). However, measurements
were complicated by the presence of posterior staphyloma. It is
of note that in the affected eyes without posterior staphylo-
mata, the axial lengths were less than 19 mm. Pigmentary
retinopathy was seen in all eyes and in the younger members
of the family there was a clearcut anterior demarcation line
between the normal and dystrophic retina (Fig 2C). Such
changes may be seen following resolution of choroidal
effusion which may complicate nanophthalmos but the ERG
findings of a widespread rod-cone dystrophy in our subjects
suggests that the pigmentary change is caused by photorecep-
tor cell death. Thus, the phenotype may reasonably be consid-
ered nanophthalmia plus posterior staphyloma, cataract, and
retinal dystrophy. Such an observation is also consistent with
our molecular genetic analyses, which suggests that the
disease gene maps within the NNO1 locus on chromosome 11.
The association of pulverulent cataract with nanophthal-
mos has not been previously recorded. The type of opacifica-
tion, so called because of its dust-like appearance, is one of the
most common phenotypes seen in human non-syndromic
congenital cataract. Molecular genetic analyses have revealed
that mutations within several genes encoding lens specific
transmembrane proteins that maintain cell homeostasis28–30
are among the many genes responsible. It is reasonable to
suggest therefore that the disease causative gene in our family
may encode a similar protein but one which is also expressed
in the retina and cornea. Alternatively, the mutation, which,
by deduction from the phenotype lies within a gene most
likely involved in eye development, might result in downregu-
lation of the expression of one or more of these transmem-
brane proteins. In keeping with the eye developmental regula-
tor, SIX5,31 this effect may extend to adulthood. The association
of a progressive rod-cone dystrophy with developmental
structural abnormalities of the eye in our family also supports
the notion that the causative gene may have both a
developmental function and probably a continuing function
after embryogenesis. This dual role is also seen in another
developmental gene, PAX6, which gives rise to a developmen-
tal ocular abnormality1 and also has a role in maintenance and
renewal of the corneal epithelium.32
The association of microcornea/nanophthalmos and pig-
mentary retinopathy have been reported previously21–23 but a
genetic locus has not been identified (Table 3). The spectrum
of ocular signs described in other families certainly overlaps
Table 2 LOD score showing exclusion data for candidate genes and loci
Locus Marker
Distance from
locus/gene
LOD score (Z) at recombination (θ) of
0 0.05 0.1 0.15 0.20 0.25 0.30 0.35 0.40
CMIC D14S267 Within locus −∞ −2.50 −1.66 −0.99 −0.57 −0.30 −0.13 −0.02 0.02
D14S987 Within locus −∞ −1.07 −0.70 −0.47 −0.31 −0.21 −0.12 −0.07 −0.03
CHX10 D14S1047 0.1Mb −∞ −0.90 −0.41 −0.18 −0.05 0.023 0.059 0.069 0.06
NNO2 D15S165 Within locus −∞ −2.60 −1.52 −0.94 −0.57 −0.32 −0.15 −0.05 0.008
D15S118 2 cM from locus −∞ −1.10 −0.63 −0.40 −0.27 −0.19 −0.12 −0.07 −0.04
Table 3 Families and sporadic reports of disorders similar to MRCS
Author(s)
Inheritance of
trait No affected Clinical features
Chromosomal
location
Gene
involved
Hermann33 AD 13 Microphthalmia, moderate myopia +/− retinitis pigmentosa ?
Mackay20 AR 7 Nanophthalmos, retinal degeneration, angle closure glaucoma ?
Bateman34 AD 4 Microcornea, coloboma, posterior staphyloma ?
Bessant et al25 AR 6 Microphthalmia, scleroderma, nystagmus 14q32 (CMIC) ?
Percin et al2 AR (2 families) 4 and 1 Microphthalmia, bilateral iris coloboma, cataracts 14q23.3 CHX10
Othman et al23 AD 16 Nanophthalmos 11p12-q13 (NNO1) ?
Morle26 AD 9 Colobomatous microphthalmia 15q12-q15 (NNO2) ?
Buys21 Sporadic 1 Nanophthalmos, retinitis pigmentosa, disc drusen ?
Ghose et al22 Sporadic 1 Nanophthalmos, microcornea, pigmentary retinal dystrophy ?
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the features of the syndrome seen in this family. Notwith-
standing, no previously published family has all the compo-
nents of MRCS. Hermann in 195833 described an autosomal
dominant disorder consisting of microphthalmia and pigmen-
tary retinopathy, which has some similarities to the family
reported here. The individuals were moderately myopic
suggesting, in the presence of microphthalmia, that posterior
staphyloma may have been present; axial length measure-
ments were not available at that time. In contrast with our
family the expressivity was extremely variable in the French
family; of the 19 family members examined, six individuals
had microphthalmia and pigmentary retinopathy and seven
individuals microphthalmos alone. Although the association
of microcornea and posterior staphyloma has been specifically
reported,34 no mention of pigmentary retinopathy was made
in the published pedigree.
To test the hypothesis that the congenital anomalies
observed in our family result from a mutation within an ocu-
lar developmental gene, we used microsatellite marker
genotyping to exclude genetic linkage in our family to several
candidate loci. After excluding linkage to other candidate loci,
a positive LOD score (2.01 at θ=0) was obtained for the
marker D11S1765 within the NNO1 locus. D11S4076 (a
marker which is 0.84 cM telomeric to D11S1765) produced a
similarly positive result (1.96 at θ=0). The small family size
militates against achieving a LOD score of 3, but the haplotype
data and the position of the putative MRCS locus within a
known nanophthalmos locus is suggestive of linkage.
Nevertheless, one cannot exclude the possibility that the dis-
ease gene may not reside at the MRCS locus, even though no
positive linkage was found at any of the known microphthal-
mia loci. Two point linkage and haplotype analysis to adjacent
markers refined the putative disease interval (MRCS) to a map
distance of 5.0 cM between markers D11S4191 and D11S1883
(Figs 1 and 4).
The putative MRCS locus on 11q13 is encompassed by the
nanophthalmia locus, NNO1. The phenotypic similarities
between this condition and the anomalies segregating in our
family suggest allelic heterogeneity and if this were the case,
the data would refine the NNO1 locus (originally localised to
14.7 cM region between 11p12 and 11q13) to a 5.0 cM inter-
val on chromosome 11q13 (Fig 4). Within the region lie
several genes that are expressed in the eye, ROM1, VMD2,
GNG3, FLJ20539, and B3GAT3. ROM1 encodes a protein found
in the outer segment disc membranes of the photoreceptor
cells of the retina and, together with peripherin/RDS gene, has
been implicated in the pathogenesis of digenic retinitis
pigmentosa.35 Although ROM1 has not been shown to have a
developmental role, we felt it warranted exclusion as a candi-
date gene. Direct sequencing of the coding and promoter
regions of the gene however did not identify a mutation.
The family reported in this paper has a rare ocular
phenotype consisting of microcornea, rod-cone dystrophy,
cataract, and posterior staphyloma (MRCS). This is likely to be
caused by a mutation in a major developmental regulator gene
and molecular genetic analysis suggests that the gene locus
may lie within the nanophthalmos locus on chromosome 11,
possibly allelic with the as yet uncharacterised NNO1 gene. We
now plan to try and identify additional families with this rare
syndrome, which may help confirm the locus, and screen
other candidate genes within the genetic interval. Identifica-
tion of the causative gene is likely to contribute significantly to
understanding the mechanisms underlying human eye devel-
opment.
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